|
Lin, Z P; Boller, Y C; Amer, S M et al. (1998) Prevention of brefeldin A-induced resistance to teniposide by the proteasome inhibitor MG-132: involvement of NF-kappaB activation in drug resistance. Cancer Res 58:3059-65
|
|
Laurencot, C M; Kennedy, K A (1995) Influence of pH on the cytotoxicity of cisplatin in EMT6 mouse mammary tumor cells. Oncol Res 7:371-9
|
|
Laurencot, C M; Andrews, P A; Kennedy, K A (1995) Inhibitors of intracellular pH regulation induce cisplatin resistance in EMT6 mouse mammary tumor cells. Oncol Res 7:363-9
|
|
Rockwell, S; Hughes, C S; Keyes, S R et al. (1993) Porfiromycin as an adjunct to radiotherapy in young and old mice. Exp Gerontol 28:281-93
|
|
Rockwell, S; Sartorelli, A C; Tomasz, M et al. (1993) Cellular pharmacology of quinone bioreductive alkylating agents. Cancer Metastasis Rev 12:165-76
|
|
Keyes, S R; Rockwell, S; Kennedy, K A et al. (1991) Distribution of porfiromycin in EMT6 solid tumors and normal tissues of BALB/c mice. J Natl Cancer Inst 83:632-7
|
|
Rockwell, S; Hughes, C S; Kennedy, K A (1991) Effect of host age on microenvironmental heterogeneity and efficacy of combined modality therapy in solid tumors. Int J Radiat Oncol Biol Phys 20:259-63
|
|
Sostman, H D; Charles, H C; Rockwell, S et al. (1990) Soft-tissue sarcomas: detection of metabolic heterogeneity with P-31 MR spectroscopy. Radiology 176:837-43
|
|
Sostman, D; Rockwell, S; Smith, G J et al. (1988) Magnetic resonance, pathology and physiology of the BA1112 rhabdomyosarcoma in vivo. Invest Radiol 23:277-88
|
